169 related articles for article (PubMed ID: 12826592)
1. Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway.
Jison ML; Gladwin MT
Am J Respir Crit Care Med; 2003 Jul; 168(1):3-4. PubMed ID: 12826592
[No Abstract] [Full Text] [Related]
2. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
Morris CR; Morris SM; Hagar W; Van Warmerdam J; Claster S; Kepka-Lenhart D; Machado L; Kuypers FA; Vichinsky EP
Am J Respir Crit Care Med; 2003 Jul; 168(1):63-9. PubMed ID: 12626350
[TBL] [Abstract][Full Text] [Related]
3. Sickle cell disease at the dawn of the molecular era.
Abboud MR; Musallam KM
Hemoglobin; 2009; 33 Suppl 1():S93-S106. PubMed ID: 20001639
[TBL] [Abstract][Full Text] [Related]
4. The use of inhaled nitric oxide in newborn medicine.
Golombek SG
Heart Dis; 2000; 2(5):342-7. PubMed ID: 11728280
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.
Morris CR; Kato GJ; Poljakovic M; Wang X; Blackwelder WC; Sachdev V; Hazen SL; Vichinsky EP; Morris SM; Gladwin MT
JAMA; 2005 Jul; 294(1):81-90. PubMed ID: 15998894
[TBL] [Abstract][Full Text] [Related]
6. Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability.
Hsu LL; Champion HC; Campbell-Lee SA; Bivalacqua TJ; Manci EA; Diwan BA; Schimel DM; Cochard AE; Wang X; Schechter AN; Noguchi CT; Gladwin MT
Blood; 2007 Apr; 109(7):3088-98. PubMed ID: 17158223
[TBL] [Abstract][Full Text] [Related]
7. Citrulline, Viagra and BiDil--bad medicine.
Czp A
Altern Med Rev; 2005 Dec; 10(4):265-7. PubMed ID: 16400750
[No Abstract] [Full Text] [Related]
8. Nitric oxide metabolism and the acute chest syndrome of sickle cell anemia.
Sullivan KJ; Kissoon N; Gauger C
Pediatr Crit Care Med; 2008 Mar; 9(2):159-68. PubMed ID: 18477929
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary hypertension, nitric oxide and nitric oxide-releasing compounds.
Hagan G; Pepke-Zaba J
Expert Rev Respir Med; 2011 Apr; 5(2):163-71. PubMed ID: 21510727
[TBL] [Abstract][Full Text] [Related]
10. New treatments for pulmonary arterial hypertension.
Hoeper MM; Galiè N; Simonneau G; Rubin LJ
Am J Respir Crit Care Med; 2002 May; 165(9):1209-16. PubMed ID: 11991870
[No Abstract] [Full Text] [Related]
11. Present role of nitric oxide inhalation in severe lung failure.
Rossaint R; Kelly K; Kaisers U
Acta Anaesthesiol Scand Suppl; 1996; 109():88-92. PubMed ID: 8901960
[No Abstract] [Full Text] [Related]
12. Use of selexipag in a child with pulmonary hypertension associated with sickle cell disease.
Das BB; Jadotte MM; Chan KC
J Heart Lung Transplant; 2020 Sep; 39(9):990-993. PubMed ID: 32418865
[No Abstract] [Full Text] [Related]
13. Sickle cell anemia and vascular dysfunction: the nitric oxide connection.
Akinsheye I; Klings ES
J Cell Physiol; 2010 Sep; 224(3):620-5. PubMed ID: 20578237
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.
Klings ES; Farber HW
N Engl J Med; 2004 Jun; 350(24):2521-2; author reply 2521-2. PubMed ID: 15190149
[No Abstract] [Full Text] [Related]
15. Hemoglobin and nitric oxide.
Pawloski JR
N Engl J Med; 2003 Jul; 349(4):402-5; author reply 402-5. PubMed ID: 12879895
[No Abstract] [Full Text] [Related]
16. Nitric oxide does not reverse pulmonary hypertension associated with end-stage liver disease: a preliminary report.
Ramsay MA; Schmidt A; Hein HA; Nguyen AT; Lynch K; East CA; Ramsay KJ; Klintmalm GB
Hepatology; 1997 Mar; 25(3):524-7. PubMed ID: 9049191
[TBL] [Abstract][Full Text] [Related]
17. Arginine metabolism and nitric oxide bioavailability in sickle cell disease.
Jain S; Gladwin MT
J Pediatr Hematol Oncol; 2010 Oct; 32(7):e247-8. PubMed ID: 20724948
[No Abstract] [Full Text] [Related]
18. Pathways to pulmonary hypertension in sickle cell disease: the search for prevention and early intervention.
Shilo NR; Morris CR
Expert Rev Hematol; 2017 Oct; 10(10):875-890. PubMed ID: 28817980
[TBL] [Abstract][Full Text] [Related]
19. Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy.
Kato GJ; Gladwin MT
JAMA; 2008 Dec; 300(22):2638-46. PubMed ID: 19066384
[TBL] [Abstract][Full Text] [Related]
20. Arginine metabolism, pulmonary hypertension, and sickle cell disease.
Kielstein JT; Cooke JP
JAMA; 2005 Nov; 294(19):2433; author reply 2433-4. PubMed ID: 16287950
[No Abstract] [Full Text] [Related]
[Next] [New Search]
